Australia markets closed

Travere Therapeutics, Inc. (TVTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.81-0.13 (-1.64%)
As of 03:11PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts10101011
Avg. Estimate-0.86-0.69-3.69-1.55
Low estimate-1.06-0.97-4.62-2.36
High estimate-0.64-0.53-2.580.25
Year ago EPS-1.131.97-1.5-3.69
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts13131416
Avg. Estimate50.17M57.77M216.54M324.56M
Low estimate47M46.8M184.37M262.27M
High estimate55M75M253M512.67M
Year ago sales59.7M37.09M145.24M216.54M
Sales growth (year/est)-16.00%55.70%49.10%49.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.14-0.14-1.27-0.99
Actual EPS-1.131.97-1.18-1.76
Difference0.012.110.09-0.77
Surprise %0.90%1,507.10%7.10%-77.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.86-0.69-3.69-1.55
7 days ago-0.86-0.69-3.69-1.55
30 days ago-0.89-0.71-3.73-1.53
60 days ago-0.8-0.72-3.18-1.77
90 days ago-0.82-0.72-3.18-1.75
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days11N/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTVTXIndustrySector(s)S&P 500
Current qtr.23.90%N/AN/AN/A
Next qtr.-135.00%N/AN/AN/A
Current year-146.00%N/AN/AN/A
Next year58.00%N/AN/AN/A
Next 5 years (per annum)245.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A